We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Group enriched (head and neck cancer, prostate cancer)
HPA (cell line):
Group enriched (EFO-21, U-2 OS)
HPA (normal tissue):
Group enriched (heart muscle, skeletal muscle)
Protein evidence
Evidence at protein level
Protein expression normal tissue
Selective cytoplasmic expression in heart and skeletal muscle.
ANTIBODY IHC RELIABILITY
Data reliability description
Antibody staining mainly consistent with RNA expression data. Caution, targets protein from more than one gene. Presumed off target binding observed and disregarded.
A subset of tumor cells in few cases of glioma showed moderate to strong cytoplasmic positivity. Several cases of squamous cell carcinomas of lung and few cases of melanoma along with papillary adenocarcinomas of thyroid displayed moderate staining. Few cases of testis, endometrial and pancreatic cancers showed membranous immunoreactivity. Remaining cancer tissues were weakly stained or negative.
Few cases of colorectal, endometrial and hepatocellular carcinomas displayed weak to moderate membranous positivity. Remaining cancer tissues were negative.
Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]
Predicted intracellular proteins Candidate cardiovascular disease genes Disease related genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)